• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Re: Alessandro Morlacco, John C. Cheville, Laureano J. Rangel, Derek J. Gearman, R. Jeffrey Karnes. Adverse Disease Features in Gleason Score 3 + 4 "Favorable Intermediate-risk" Prostate Cancer: Implications for Active Surveillance. Eur Urol 2017;72:442-7.

作者信息

Du Chen, Chen Hui, Li Changfu

机构信息

Department of Urology, Harbin Medical University Cancer Hospital, Harbin, People's Republic of China.

Department of Urology, Harbin Medical University Cancer Hospital, Harbin, People's Republic of China.

出版信息

Eur Urol. 2017 Nov;72(5):e125. doi: 10.1016/j.eururo.2017.01.040. Epub 2017 Feb 3.

DOI:10.1016/j.eururo.2017.01.040
PMID:28169017
Abstract
摘要

相似文献

1
Re: Alessandro Morlacco, John C. Cheville, Laureano J. Rangel, Derek J. Gearman, R. Jeffrey Karnes. Adverse Disease Features in Gleason Score 3 + 4 "Favorable Intermediate-risk" Prostate Cancer: Implications for Active Surveillance. Eur Urol 2017;72:442-7.回复：亚历山德罗·莫拉科、约翰·C·切维尔、劳雷亚诺·J·兰热尔、德里克·J·吉尔曼、R·杰弗里·卡恩斯。 Gleason评分3+4“有利的中危”前列腺癌的不良疾病特征：对主动监测的影响。《欧洲泌尿外科杂志》2017年；72卷：442 - 447页
Eur Urol. 2017 Nov;72(5):e125. doi: 10.1016/j.eururo.2017.01.040. Epub 2017 Feb 3.
2
Reply to Thomas Van den Broeck, R. Jeffrey Karnes, and Steven Joniau's Letter to the Editor re: Amar U. Kishan, Talha Shaikh, Pin-Chieh Wang, et al. Clinical Outcomes for Patients with Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiotherapy or Radical Prostatectomy: A Multi-institutional Comparative Analysis. Eur Urol 2017;71:766-73.对托马斯·范登·布罗克、R.杰弗里·卡恩斯和史蒂文·乔尼奥的致编辑信的回复，信的内容涉及阿马尔·U.基尚、塔尔哈·谢赫、平杰·王等人的《接受放疗或根治性前列腺切除术的 Gleason 评分 9 - 10 前列腺腺癌患者的临床结局：多机构比较分析》。《欧洲泌尿外科杂志》2017 年；71:766 - 73。
Eur Urol. 2017 Nov;72(5):e123-e124. doi: 10.1016/j.eururo.2017.01.017. Epub 2017 Jan 19.
3
Re: Alberto Martini, Giorgio Gandaglia, R. Jeffrey Karnes, et al. Defining the Most Informative Intermediate Clinical Endpoints for Predicting Overall Survival in Patients Treated with Radical Prostatectomy for High-risk Prostate Cancer. Eur Urol Oncol 2019;2:456-63.回复：阿尔贝托·马尔蒂尼、乔治·甘达利亚、R·杰弗里·卡恩斯等。确定预测高危前列腺癌根治性前列腺切除术患者总生存期最具信息价值的中间临床终点。《欧洲泌尿外科肿瘤学》2019年；2：456 - 63。
Eur Urol Oncol. 2019 Jul;2(4):472-473. doi: 10.1016/j.euo.2019.01.012. Epub 2019 Jan 30.
4
Re: Radiation therapy after radical prostatectomy: impact on metastasis and survival S. A. Boorjian, R. J. Karnes, P. L. Crispen, L. J. Rangel, E. J. Bergstralh and M. L. Blute J Urol 2009; 182: 2708-2715.
J Urol. 2010 Jun;183(6):2466-7; author reply 2467. doi: 10.1016/j.juro.2010.02.040. Epub 2010 Apr 18.
5
Re: R. Jeffrey Karnes, Voleak Choeurng, Ashley E. Ross, et al. Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2017.03.036.
Eur Urol. 2017 Dec;72(6):e157. doi: 10.1016/j.eururo.2017.05.031. Epub 2017 May 31.
6
Reply to Pim J. van Leeuwen and Henk G. van der Poel's Letter to the Editor re: Karim A. Touijer, Robert J. Karnes, Niccolo Passoni, et al. Survival Outcomes of Men with Lymph Node-positive Prostate Cancer After Radical Prostatectomy: A Comparative Analysis of Different Postoperative Management Strategies. Eur Urol 2018;73:890-6.对皮姆·J·范·李文和亨克·G·范·德·波尔致编辑的信的回复，信的内容涉及卡里姆·A·图耶尔、罗伯特·J·卡恩斯、尼科洛·帕索尼等人的《根治性前列腺切除术后淋巴结阳性前列腺癌男性的生存结果：不同术后管理策略的比较分析》。《欧洲泌尿外科杂志》2018年；73卷：890 - 896页。
Eur Urol. 2018 Jul;74(1):e18-e19. doi: 10.1016/j.eururo.2018.04.002.
7
Reply to Erfan Ayubi and Saeid Safiri's Letter to the Editor re: R. Jeffrey Karnes, Voleak Choeurng, Ashley E. Ross, et al. Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2017.03.036. Methodological Issues.对埃尔凡·阿尤比和赛义德·萨菲里致编辑的信的回复，主题为：R. 杰弗里·卡恩斯、沃莱克·乔恩、阿什利·E. 罗斯等人。用于预测具有不良病理特征男性前列腺癌特异性死亡率的基因组风险分类器的验证。《欧洲泌尿外科杂志》。即将发表。https://doi.org/10.1016/j.eururo.2017.03.036。方法学问题。
Eur Urol. 2017 Dec;72(6):e158-e159. doi: 10.1016/j.eururo.2017.05.030. Epub 2017 May 31.
8
Population based study of predictors of adverse pathology among candidates for active surveillance with Gleason 6 prostate cancer.基于人群的研究：预测前列腺癌 Gleason6 评分患者主动监测不良病理的因素。
J Urol. 2014 Feb;191(2):350-7. doi: 10.1016/j.juro.2013.09.034. Epub 2013 Sep 23.
9
Pathological outcome for Chinese patients with low-risk prostate cancer eligible for active surveillance and undergoing radical prostatectomy: comparison of six different active surveillance protocols.适合积极监测并接受根治性前列腺切除术的中国低风险前列腺癌患者的病理结果：六种不同积极监测方案的比较
Hong Kong Med J. 2017 Dec;23(6):609-15. doi: 10.12809/hkmj166194. Epub 2017 Oct 13.
10
Identification of pathologically favorable disease in intermediate-risk prostate cancer patients: Implications for active surveillance candidates selection.中危前列腺癌患者中病理特征良好疾病的识别：对主动监测候选者选择的意义
Prostate. 2015 Sep;75(13):1484-91. doi: 10.1002/pros.23040. Epub 2015 Jul 14.